Abstract

Ethnopharmacological relevance Salvia miltiorrhiza Bunge, a traditional Chinese medicinal herb, has been clinically utilized in the management of diabetic kidney disease (DKD). However, the specific bioactive components and molecular mechanisms underlying its renoprotective effects remain unclear. Aim of the study This study aimed to identify active compounds from Salvia miltiorrhiza Bunge capable of attenuating podocyte pyroptosis and to elucidate its molecular mechanisms in DKD. Materials and methods Bioactive compounds were systematically screened using a Gaussia luciferase reporter assay, and further validated by measuring both the survival rate and LDH release in advanced glycation end product (AGE)-induced MPC-5 cells. The efficacy of potential active ingredient was evaluated in db/db mice through detecting urinary microalbumin, albumin-to-creatinine ratio, serum creatinine, blood urea nitrogen and renal histopathology. Molecular mechanisms were investigated via western blotting, immunohistochemistry, and functional validation using the specific NLRP3 activator (Nigericin), siRNA of A20 and miRNA-21 mimics. Results Systematic screening identified salvianolic acid C (Sal C) as a potent inhibitor of AGE-induced pyroptosis in MPC-5 cells. Subsequently, Sal C could significantly ameliorate renal dysfunction and podocyte injury in db/db mice, evidenced by improving parameters of renal function and attenuating glomerular pathology. Mechanistically, Sal C suppressed the NLRP3/Caspase-1/GSDMD pathway activation in vitro and in vivo . Co-treatment with Nigericin, a specific NLRP3 activator, attenuated the protective effects of Sal C against podocyte injury. Crucially, Sal C upregulated miRNA-21 expression, leading to enhanced A20 expression. Both A20 siRNA and miRNA-21 mimics abolished the inhibitory effect of Sal C on NLRP3/Caspase-1/GSDMD pathway-mediated p